Evaluation of MR Relaxation Times Following Trastuzumab Treatment of Breast Cancer Cells in a 3D Bioreactor

Acta Poloniae Pharmaceutica - Poland
doi 10.32383/appdr/115519
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Polish Pharmaceutical Society

Related search

Late Characterisation of Cardiac Effects Following Anthracycline and Trastuzumab Treatment in Breast Cancer Patients

International Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Expression of T-Darpp Mediates Trastuzumab Resistance in Breast Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2008English

Fetal Renal Insufficiency Following Trastuzumab Treatment for Breast Cancer in Pregnancy: Case Report Und Review of the Current Literature

Breast Care
SurgeryOncology
2011English

Trastuzumab in the Treatment of Metastatic Breast Cancer : Anticancer Therapy Versus Cardiotoxicity

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Trastuzumab-Resistance and Breast Cancer

2011English

Immunoselection of Breast and Ovarian Cancer Cells With Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells

Cancer Research
Cancer ResearchOncology
2009English

Women With Early Breast Cancer to Be Tested for Trastuzumab Treatment

BMJ
2005English

Evaluation of Radiation-Induced Cardiac Toxicity in Breast Cancer Patients Treated With Trastuzumab-Based Chemotherapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy